T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.345
-0.014 (-3.87%)
At close: Dec 24, 2024, 1:00 PM
0.380
+0.035 (10.14%)
Pre-market: Dec 26, 2024, 7:53 AM EST
T2 Biosystems Employees
T2 Biosystems had 113 employees as of December 31, 2023. The number of employees decreased by 45 or -28.48% compared to the previous year.
Employees
113
Change (1Y)
-45
Growth (1Y)
-28.48%
Revenue / Employee
$67,938
Profits / Employee
-$380,124
Market Cap
7.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Trinity Biotech | 380 |
PAVmed | 107 |
Biofrontera | 85 |
Elevai Labs | 18 |
Virax Biolabs Group | 17 |
Soligenix | 15 |
QT Imaging Holdings | 14 |
GT Biopharma | 2 |
TTOO News
- 9 days ago - T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. - GlobeNewsWire
- 16 days ago - T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens - GlobeNewsWire
- 5 weeks ago - T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 - GlobeNewsWire
- 2 months ago - T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript - Seeking Alpha
- 2 months ago - T2 Biosystems to Host Business Update Call on October 10, 2024 - GlobeNewsWire
- 2 months ago - T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens - GlobeNewsWire
- 3 months ago - T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union - GlobeNewsWire